Aridis Pharmaceuticals, Inc.
Aridis Pharmaceuticals, Inc. (ARDS) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 15 transactions totaling $181.5K, demonstrating a bullish sentiment with $181.5K in net insider flow. The most recent transaction on Jun 24, 2024 involved a purchase of 714,286 shares valued at $50.0K.
ARDS Insider Activity Summary
Who Is Buying ARDS Stock?
No significant insider buying has been recorded for ARDS in the recent period.
Who Is Selling ARDS Stock?
No significant insider selling has been recorded for ARDS in the recent period.
Is Aridis Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ARDS is bullish with an Insider Alignment Score of 100/100 and a net flow of $181.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ARDS Frequently Asked Questions
Understanding ARDS Insider Activity
Insider trading at Aridis Pharmaceuticals, Inc. (ARDS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading ARDS stock, having executed 15 transactions in the past 90 days. The most active insider is Vu Truong (Executive), who has made 3 transactions totaling $75.6K.
Related Tools
Track Aridis Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at ARDS file new Form 4 transactions